Back
Insperity, Inc. Vs. Abivax SA Industry Stock Comparison
Sell
22
NSP
Insperity, Inc.
Last Price:
$38.01
Seasonality Move:
3.23%
Buy
52
ABVX
Abivax SA
Last Price:
$138.50
Seasonality Move:
10.39%
Sell
22
Insperity, Inc. (NSP)
is a Sell
Is Insperity, Inc. a Buy, Sell or Hold?
-
The current Insperity, Inc. [NSP] share price is $38.92. The Score for NSP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
NSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NSP Stock Price Chart
What is Insperity, Inc.'s stock price today?
-
The Insperity, Inc. share price today is $38.92The current trend is relatively stagnant and NSP is experiencing slight buying pressure.
NSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 57.12 | Buy |
| Chaikin Money Flow: | 309650 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.48 - 38.2) | Buy |
| Bollinger Bands (100): | (37.53 - 52.83) | Sell |
ABVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.49 | Buy |
| Relative Strength Index (14 RSI): | 66.41 | Buy |
| Chaikin Money Flow: | 3795582 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (112.09 - 127.03) | Buy |
| Bollinger Bands (100): | (76.86 - 112.16) | Buy |
NSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.77 | Buy |
| 20-day SMA: | 36.68 | Buy |
| 50-day SMA: | 38.79 | Buy |
| 200-day SMA: | 57.93 | Sell |
| 8-day EMA: | 38.41 | Buy |
| 20-day EMA: | 37.41 | Buy |
| 50-day EMA: | 39.47 | Sell |
| 200-day EMA: | 54.87 | Sell |
ABVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.7 | Buy |
| 20-day SMA: | 120.33 | Buy |
| 50-day SMA: | 108.99 | Buy |
| 200-day SMA: | 52.89 | Buy |
| 8-day EMA: | 121.32 | Buy |
| 20-day EMA: | 118.51 | Buy |
| 50-day EMA: | 109.04 | Buy |
| 200-day EMA: | 67.23 | Buy |
Insperity, Inc. Earnings Growth & NSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.39 per share, and an increase next year of $1.40 per share.
Abivax SA Earnings Growth & ABVX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.37 per share, and an increase next year of $1.13 per share.
Insperity, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Abivax SA Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||